Skip to main content
. Author manuscript; available in PMC: 2021 May 3.
Published in final edited form as: J Hypertens. 2020 Dec;38(12):2435–2442. doi: 10.1097/HJH.0000000000002571

FIGURE 2.

FIGURE 2

Overall scheme showing dietary precursors of 1-methylhistidine and its proposed relevance in the development of hypertension. 1. Carnosinase catalyzes conversion of dietary anserine into ß-alanine and 1-methylhistidine predominantly in systemic circulation. 2. Cumulative exposure to dietary 1-methylhistidine may increase risk for both obesity and nonalcoholic fatty liver disease, two independent risk factors for hypertension.